Pages that link to "Q46278994"
Jump to navigation
Jump to search
The following pages link to Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo (Q46278994):
Displaying 50 items.
- Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment (Q26738359) (← links)
- Advances in immunotherapy for treatment of lung cancer (Q26778790) (← links)
- CD28 co-stimulation in T-cell homeostasis: a recent perspective (Q27007031) (← links)
- Inhibition of M-tropic HIV-1 infection by the fd phage-gene 3 protein with MIP-1alpha-binding activity (Q28370863) (← links)
- Ipilimumab: from preclinical development to future clinical perspectives in melanoma (Q30240751) (← links)
- The role of CTLA-4 in the regulation of T cell immune responses. (Q33547785) (← links)
- Regulation of the small GTPase Rap1 and extracellular signal-regulated kinases by the costimulatory molecule CTLA-4. (Q33770495) (← links)
- Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody (Q34002747) (← links)
- Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy (Q34149569) (← links)
- CTLA-4: new insights into its biological function and use in tumor immunotherapy (Q34711491) (← links)
- Differentiation-dependent differences in murine T cell susceptibility to negative regulation by the lung (Q34985612) (← links)
- Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells (Q35405162) (← links)
- In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. (Q35653114) (← links)
- CD28 ligation increases macrophage suppression of T-cell proliferation. (Q36075815) (← links)
- Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer (Q36301801) (← links)
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells (Q36366857) (← links)
- Protective immunity to nematode infection is induced by CTLA-4 blockade (Q36380414) (← links)
- Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes (Q36400199) (← links)
- Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells (Q36401309) (← links)
- Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer (Q36589870) (← links)
- Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models (Q37126642) (← links)
- CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance (Q37157989) (← links)
- Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1. (Q38004628) (← links)
- Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma (Q38160837) (← links)
- Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose? (Q38680348) (← links)
- Targeting PD-1/PD-L1 in lung cancer: current perspectives (Q38956294) (← links)
- The "Achilles Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies. (Q39384440) (← links)
- Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice (Q40696119) (← links)
- Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors (Q40786472) (← links)
- CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens (Q40900024) (← links)
- Costimulation and autoimmunity (Q41312371) (← links)
- Co-stimulation in T cell responses. (Q41514667) (← links)
- The emerging role of CTLA-4 as an immune attenuator (Q41630509) (← links)
- Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help. (Q41827708) (← links)
- A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response? (Q41928232) (← links)
- A systemic complete response of metastatic melanoma to local radiation and immunotherapy. (Q42701258) (← links)
- Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation (Q43511547) (← links)
- Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells (Q46091258) (← links)
- The role of tyrosine phosphorylation and PTP-1C in CTLA-4 signal transduction. (Q46125201) (← links)
- Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. (Q46208882) (← links)
- Evaluation of immune responses in mice and sheep inoculated with a live attenuated Brucella melitensis REV1 vaccine produced in bioreactor. (Q52344256) (← links)
- CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice (Q56903604) (← links)
- Human CD1a molecule expressed on monocytes plays an accessory role in the superantigen-induced activation of T lymphocytes (Q73480226) (← links)
- Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies (Q73676653) (← links)
- Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigen (Q74086242) (← links)
- Tumor-growth inhibition with bispecific antibody fragments in a syngeneic mouse melanoma model: the role of targeted T-cell co-stimulation via CD28 (Q77959556) (← links)
- Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions (Q88922346) (← links)
- The different benefits and side effects of nivolumab combined with ipilimumab in diverse cancer: A Protocol for Systematic Review (Q90352646) (← links)
- Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives (Q92434452) (← links)
- The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity (Q92890914) (← links)